GLI1 and squamous cell carcinoma: Other studies described the contribution of the canonical cell signaling SHH-GLI1 axis to acquired chemoresistance to doxorubicin, vincristine, and etoposide in both non-solid tumor-derived K-562 erythroid leukemia cells and solid tumor-derived epidermoid carcinoma KB cells [35].